Article
Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country.
Pediatric blood & cancer - 1 Nov 2022
El Khatib Omar, Yahya Yasser, Mahfouz Rami, Hamadeh Lama, Basbous Maya, Abboud Miguel R, Muwakkit Samar, Rodriguez-Galindo Carlos, Jeha Sima, Saab Raya
Abstract excerpt
Resource-limited settings often have financial barriers to genetic testing for heritable cancer. This retrospective study investigated the pattern of heritable cancer predisposition testing in a middle-income country over the period 2014-2021, excluding retinoblastoma. After establishing a specific fund in 2019, rate of tests increased from 1.1% to 10.9% of new diagnoses. Most common testing was for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
